AksharChem India Not Large Corporate: ₹27.96 Cr Borrowing, CARE A- Rating

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
AksharChem India Not Large Corporate: ₹27.96 Cr Borrowing, CARE A- Rating
Overview

AksharChem India Ltd has confirmed it is not a 'Large Corporate' under SEBI's definition for debt issuance. The company reported ₹27.96 crore in borrowings as of March 31, 2026, and holds a CARE A- (Stable) credit rating. This status exempts AksharChem from specific SEBI compliance rules for debt securities and affects its fundraising disclosures.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

AksharChem India Confirms Non-Large Corporate Status

AksharChem India Ltd has officially informed the BSE and NSE that it does not meet SEBI's criteria for a 'Large Corporate' (LC). This confirmation stems from its financial position as of March 31, 2026, which shows outstanding borrowings of ₹27.96 crore. The company holds a long-term credit rating of 'CARE A-; Stable' and a short-term rating of 'CARE A2+' from CARE Ratings Limited. As a result, AksharChem is not bound by the stricter compliance rules that SEBI imposes on Large Corporates for issuing debt securities.

SEBI Rules for Large Corporates

The SEBI 'Large Corporate' rules, designed to boost the corporate bond market, require certain companies to raise a minimum percentage of their new borrowings through debt securities. This initiative aims to deepen capital market access for larger entities.

AksharChem's Current Standing

By confirming it is not a Large Corporate, AksharChem India is exempt from these mandatory debt issuance requirements. The company avoids specific LC borrowing thresholds and benefits from simplified disclosure obligations related to its debt activities. This clarity aids in structuring its fundraising efforts.

Background on the Framework

SEBI's Large Corporate framework was established on November 26, 2018. It originally required companies with over ₹1,000 crore in long-term borrowings and an AA or higher credit rating to raise at least 25% of their new borrowings through debt securities. AksharChem had previously been identified as a Large Corporate, with past filings showing ₹23.47 crore in borrowings and an A+ credit rating. SEBI has since updated the framework multiple times, with the latest revisions taking effect on April 1, 2024, aiming to balance market growth with business practicality.

Potential Future Risks

The SEBI framework includes a penalty of 0.2% of any shortfall for companies that are classified as Large Corporates but fail to meet their mandatory debt security issuance quotas. This risk is contingent on AksharChem's future borrowing levels or credit rating changes that could move it back into the LC category.

Sector Context

AksharChem operates in the chemicals sector with peers such as Sudarshan Chemical, Bodal Chemicals, and Kiri Industries. While all companies navigate regulatory landscapes, the SEBI 'Large Corporate' classification applies specifically to entities meeting its defined criteria for debt issuance scale and creditworthiness.

What to Watch Next

Investors will likely monitor AksharChem's future debt issuance plans for alignment with its non-LC status. Tracking any changes in the company's outstanding borrowings or credit rating will be key, as these could affect its classification. Further updates to SEBI's 'Large Corporate' framework and AksharChem's ongoing financial performance will also be points of interest.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.